An Empirical vs Risk-Based Approach Algorithm to Intracavernosal Injection Therapy: A Prospective Study.

Area of Science:

• Urology
• Sexual Medicine
• Pharmacology

Background:

• Intracavernosal injection (ICI) is a common treatment for erectile dysfunction (ED).
• Current ICI practices are often empirical, lacking evidence-based validation.
• A comparison between risk-based and empiric ICI strategies is needed.

Purpose of the Study:

• To compare the efficacy, patient satisfaction, and complication rates of risk-based versus empiric ICI strategies for ED.
• To assess the impact of two distinct ICI approaches on sexual function domains.

Main Methods:

• A prospective study compared two groups: empiric ICI (prostaglandin E1) and risk-based ICI (bimix or trimix based on ED factors).
• Patient-reported outcomes included IIEF-EF, QEQ, SQoL, and EDITS scores, assessed at baseline, 3, and 6 months.
• Statistical analysis used t-tests and chi-squared analysis to compare outcomes and complication rates.

Main Results:

• Both ICI approaches significantly improved sexual function scores (QEQ, SQoL, IIEF-EF).
• No statistically significant differences were found in IIEF, QEQ, SQoL, or EDITS scores between the empiric and risk-based groups at 3 or 6 months.
• Complication rates were similar, though priapism and pain were slightly higher in the risk-based group at 3 months.

Conclusions:

• Empiric and risk-based ICI strategies yield comparable improvements in sexual function and patient satisfaction for ED.
• Neither ICI approach demonstrated superiority in terms of efficacy, satisfaction, or overall complication rates.
• Clinicians can utilize either empiric or risk-based ICI therapy for ED management with similar expected outcomes.